KLOW peptide dosage: what each study gave
A common vial holds 80 mg, but that doesn't set an amount for a person. Your body clears each drug at its own rate.
The short version: why study amounts aren't a dose
KLOW peptide joins four short chains of protein parts in one vial. Researchers chose a different amount of each drug for each test. Their work did not find an amount for a person to use, and no fair human study has set one. A typical lab vial contains 80 mg, with most of its weight from GHK-Cu. BPC-157, TB-500, and KPV make up smaller shares. Some tests used rats or mice; others used dishes of cells, skin creams, or a vein in a test with two adults. Combining those figures can't produce a useful KLOW amount for you. The drugs also enter and leave your body at unequal rates, so one shot won't make their blood levels match. The figures belong to studies; they can't direct your care.
Why KLOW peptide dosage remains unknown
A typical lab vial contains 80 mg in all. It has 50 mg of GHK-Cu, 10 mg of BPC-157, 10 mg of TB-500, and 10 mg of KPV. Lab workers add germ-free water, which can slow the growth of germs. GHK-Cu accounts for about 62.5% of the vial's weight.
Those figures describe the contents. Nothing on that label can set an amount that is safe or useful for you. Researchers changed the animal, the amount, and the way they gave each drug. The figures below only show what went into those separate tests. Adding them won't make a KLOW dose for your body.
What each klow dosage study gave
BPC-157 amounts in studies. Rats with hurt tissue got daily shots into the open space inside the belly. Each rat received 10 micrograms, 10 nanograms, or 10 picograms [2]; the last unit, picogram, means one trillionth of a gram. In a 2025 safety test, two healthy adults got BPC-157 through a vein. On day 1 they received 10 mg, and on day 2 they received 20 mg. The drug went into 250 milliliters of salt water during a 1-hour period [6]. That small test looked for harm, not healing, so it can't guide your amount or your hopes.
GHK-Cu amounts in studies. Cell work used 1 to 10 nanomolar, meaning a very small amount mixed into liquid [5]. Human studies put GHK-Cu on skin. A 2017 burn study wrapped it in fat and spread it on mouse wounds [10]. A 2015 review covered several skin creams [4]. None tested KLOW on you or inside your body.
KPV amounts in studies. Very small amounts went on human immune cells and gut cells living in lab dishes [3]. Mice with bowel swelling drank water containing 100 micromolar KPV, a measure of the water mixture's strength [3]. You can't turn the mouse amount into your dose or schedule.
TB-500 and thymosin beta-4 amounts. In a 1999 wound study, rats received full thymosin beta-4 on their skin and in shots. An amount as small as 10 trillionths of a gram made skin cells move in a dish [1]. TB-500 is a brief section of that protein, so the two aren't equal.
Why KLOW peptide dosage and frequency don't match
Studies don't give a sound KLOW peptide dosage and frequency for people. Researchers gave rats daily BPC-157 shots into the open space inside the belly [2]. Other drugs went on wounds [1][10]. Mice drank KPV in water [3]. Those one-drug methods don't set a plan for you or the full mix. Lab workers often keep mixed drugs cold. Researchers haven't shown how long KLOW remains usable in water or at room heat. Copper from GHK-Cu might also change the other drugs in the liquid. No one has checked that mix well enough for your use.
Timing adds another problem. In rats, BPC-157 fell away in under about 30 minutes. KPV and GHK-Cu may disappear sooner. Much less is known about TB-500 than about full thymosin beta-4. One timing plan won't keep all four blood levels matched. The studies therefore can't tell you how often KLOW could be used safely.
How each drug entered the study subject
Rodents got BPC-157 through joint shots, shots under the skin, or shots into the open space inside the belly. Some rodents got it by mouth. In a 2025 test, two people received it through a vein [6]. GHK-Cu often went on human skin or mouse wounds. Other tests watched cells living in lab dishes [10]. Mice drank KPV in water during bowel studies. A tiny opening in each human gut cell let KPV enter [3]. Researchers put full thymosin beta-4 and its TB-500 part on rodent wounds or gave them in shots. A newer dressing carried the full protein into hurt tissue [14].
Each way of giving a drug belonged to a one-drug study. None shows you where or how to give KLOW. No human route has been set for the mix or your injury.